节点文献

我国医用聚氯乙烯增塑剂的发展现状

Current Progress in Plasticizers for Medical Poly (vinyl chloride)s in China

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 李翠翠何成生樊翠蓉钟银屏

【Author】 LI Cuicui,HE Chengsheng,FAN Cuirong,ZHONG Yinping(College of Polymer Science & Engineering,Sichuan University,Chengdu 610065)

【机构】 四川大学高分子科学与工程学院

【摘要】 我国医用聚氯乙烯(PVC)以可致癌的邻苯二甲酸二辛酯(DOP)为主增塑剂,这严重影响了国内人民的健康和医用PVC行业的发展。通过对国内外各新型环保增塑剂的比较可知:无毒环保的乙酰柠檬酸三丁酯(ATBC)适合作为我国医用PVC制品的主增塑剂。这为改善医用PVC制品使用者的健康状态,加快医用环保PVC行业的发展提出了可行性。

【Abstract】 Dioctyl phthalate(DOP)currently is the main plasticizer for medical poly(vinyl chloride)s(PVCs)in China.Due to its potentially cancer-inducing and toxic risks,DOP has caused problems to patients’ health,preventing the development of national industry of medical PVCs.The development of environment-friendly plasticizers in the world is focused in this article.It can be seen that acetyl tributyl citrate(ATBC)may be one of the best plasticizer for medical PVCs.Such plasticizer can improve safty and quality of PVC products,thereby accerlerating the development of medical PVC industry in China.

  • 【分类号】TQ414.8
  • 【被引频次】22
  • 【下载频次】1025
节点文献中: 

本文链接的文献网络图示:

本文的引文网络